'Rbv dose' presentation slideshows

The next generation of Treatment for Hepatitis C

The next generation of Treatment for Hepatitis C. Treatment of CHC: Outcomes. Goal of therapy is to render the patient PCR negative for HCV RNA Need to remain PCR negative 6 months after end of therapy Response rates for combination therapy Genotype 1 up to 40% Genotypes 2 or 3 up to 80%.

307 views • 22 slides

Edited by Morris Sherman MD BCh PhD FRCP(C) Associate Professor of Medicine

215 views • 12 slides

How to optimize treatment of G1 patients?

How to optimize treatment of G1 patients?. Prof. G. K. K. Lau 2012. Introduction. Standard of care (SOC) for chronic HCV infection Peginterferon ( PegIFN ) + ribavirin (RBV) 48 weeks (HCV G1, 4, 5 and 6) 24 weeks (HCV G2 and 3)

289 views • 12 slides